Showing results (61-70 of 285) with videos related to

Sort By:
Pageof 29
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2019
Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the Treatment of Melanoma Brain MetastasesGautham Gampa, Minjee Kim, Afroz S Mohammad, et al.
Current Pharmacology Reports|May 27, 2017
Challenges in the delivery of therapies to melanoma brain metastasesGautham Gampa, Shruthi Vaidhyanathan, Brynna-Wilken Resman, et al.
Pharmaceutical Research|July 14, 2018
Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision MedicineMinjee Kim, Sani H Kizilbash, Janice K Laramy, et al.
JCI Insight|October 9, 2025
Methylation-induced suppression of YAP/TAZ confers sensitivity to HDAC inhibitors in high-grade IDH mutant gliomasThomas K Sears, Matthew McCord, Wenxia Wang, et al.
Plos One|March 23, 2018
Presence of stromal cells in a bioengineered tumor microenvironment alters glioblastoma migration and response to STAT3 inhibitionR Marisol Herrera-Perez, Sherry L Voytik-Harbin, Jann N Sarkaria, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2018
Brain Distribution of a Novel MEK Inhibitor E6201: Implications in the Treatment of Melanoma Brain MetastasesGautham Gampa, Minjee Kim, Nicholas Cook-Rostie, et al.
Pharmaceutics|May 28, 2022
IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade GliomaJulian S Rechberger, Kendra A Porath, Liang Zhang, et al.
Plos One|February 28, 2019
Fluorescent reporter assays provide direct, accurate, quantitative measurements of MGMT status in human cellsZachary D Nagel, Andrew A Beharry, Patrizia Mazzucato, et al.
Pageof 29